Cargando…
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling
Parathyroid carcinoma (PC) is an ultra‐rare malignancy with a high risk of recurrence after surgery. Tumour‐directed systemic treatments for PC are not established. We used whole‐genome and RNA sequencing in four patients with advanced PC to identify molecular alterations that could guide clinical m...
Autores principales: | Teleanu, Maria‐Veronica, Fuss, Carmina T., Paramasivam, Nagarajan, Pirmann, Sebastian, Mock, Andreas, Terkamp, Christoph, Kircher, Stefan, Landwehr, Laura‐Sophie, Lenschow, Christina, Schlegel, Nicolas, Stenzinger, Albrecht, Jahn, Arne, Fassnacht, Martin, Glimm, Hanno, Hübschmann, Daniel, Fröhling, Stefan, Kroiss, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323885/ https://www.ncbi.nlm.nih.gov/pubmed/36808802 http://dx.doi.org/10.1002/1878-0261.13398 |
Ejemplares similares
-
Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management
por: Lenschow, Christina, et al.
Publicado: (2021) -
Detection of Structural Variants in Circulating Cell-Free DNA from Sarcoma Patients Using Next Generation Sequencing
por: Mc Connell, Lauren, et al.
Publicado: (2020) -
Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL
por: Jaramillo, Sonia, et al.
Publicado: (2020) -
Evaluation of diagnostic efficacy for localization of parathyroid adenoma in patients with primary hyperparathyroidism undergoing repeat surgery
por: Hendricks, Anne, et al.
Publicado: (2021) -
Community-driven development of a modified progression-free survival ratio for precision oncology
por: Mock, Andreas, et al.
Publicado: (2019)